Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Chest
Carlo PatronoGerald Roth

Abstract

This article discusses platelet active drugs as part of the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines. New data on antiplatelet agents include the following: (1) the role of aspirin in primary prevention has been the subject of recommendations based on the assessment of cardiovascular risk; (2) an increasing number of reports suggest a substantial interindividual variability in the response to antiplatelet agents, and various phenomena of "resistance" to the antiplatelet effects of aspirin and clopidogrel; (3) the benefit/risk profile of currently available glycoprotein IIb/IIIa antagonists is substantially uncertain for patients with acute coronary syndromes who are not routinely scheduled for early revascularization; (4) there is an expanding role for the combination of aspirin and clopidogrel in the long-term management of high-risk patients; and (5) the cardiovascular effects of selective and nonselective cyclooxygenase-2 inhibitors have been the subject of increasing attention.

References

Oct 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J W BurchP W Majerus
Sep 13, 1979·The New England Journal of Medicine·H R HarterC A Weerts
May 1, 1977·Stroke; a Journal of Cerebral Circulation·W S FieldsR J Hardy
Jul 13, 1978·The New England Journal of Medicine·UNKNOWN Canadian Cooperative Study Group
Feb 1, 1978·The Journal of Clinical Investigation·J W BurchP W Majerus
Aug 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·G J RothP W Majerus
Mar 10, 1977·The New England Journal of Medicine·L A Moroz
Sep 1, 1975·The Journal of Clinical Investigation·G J Roth, P W Majerus
Nov 27, 1992·Journal of Medicinal Chemistry·G D HartmanG Zhang
Dec 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·B FarrellC Warlow
Aug 15, 1991·The New England Journal of Medicine·UNKNOWN North American Symptomatic Carotid Endarterectomy Trial CollaboratorsM Eliasziw
Oct 17, 1991·The New England Journal of Medicine·R J ClarkeG A FitzGerald
Oct 31, 1991·The New England Journal of Medicine·UNKNOWN Dutch TIA Trial Study GroupAnet van Latum
Jul 1, 1990·Circulation·G A FitzGerald
Nov 29, 1990·The New England Journal of Medicine·UNKNOWN Boston Area Anticoagulation Trial for Atrial Fibrillation InvestigatorsJ Philip Kistler
Jan 1, 1990·European Journal of Clinical Pharmacology·A G RebuzziG Ciabattoni
Jan 1, 1990·Seminars in Thrombosis and Hemostasis·R P Rodgers, J Levin
Mar 22, 1990·The New England Journal of Medicine·UNKNOWN Stroke Prevention in Atrial Fibrillation Study Group Investigators
Dec 1, 1986·Journal of the American College of Cardiology·L A Harker, V Fuster
Feb 16, 1989·The New England Journal of Medicine·A PierucciC Patrono
Jul 20, 1989·The New England Journal of Medicine·UNKNOWN Steering Committee of the Physicians' Health Study Research Group
Oct 27, 1988·The New England Journal of Medicine·P ThérouxP deGuise
Jun 1, 1987·The Journal of Clinical Investigation·F GaspariG Remuzzi
Jan 30, 1988·British Medical Journal·R PetoS Norton
May 14, 1987·The New England Journal of Medicine·G A FitzGerald
Nov 28, 1985·The New England Journal of Medicine·J A CairnsM G Myers
Jan 1, 1985·Clinical Pharmacology and Therapeutics·A K Pedersen, G A FitzGerald
Dec 1, 1985·Circulation·C PatronoL Forni
Feb 1, 1986·The Journal of Clinical Investigation·C PatronoG A FitzGerald
Jan 1, 1985·Stroke; a Journal of Cerebral Circulation·B B WekslerD E Levy
Apr 13, 1968·Lancet·J R O'Brien

❮ Previous
Next ❯

Citations

Jun 13, 2006·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Thomas Lecompte, Jean-François Hardy
Mar 5, 2008·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·B OppedijkC F Melissant
Apr 13, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Anders GabrielsenGöran K Hansson
Apr 27, 2013·Neuroradiology·Anne J SchmittMonika Killer-Oberpfalzer
Sep 6, 2006·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Marcus C KorinthMartin R Weinzierl
Jun 8, 2007·Journal of Thrombosis and Thrombolysis·Andrew D AtiemoMarlene S Williams
Jun 23, 2009·Journal of Thrombosis and Thrombolysis·Nabeel AhmedGraham J Davies
Jul 6, 2012·Journal of Thrombosis and Thrombolysis·Vandana SharmaAnjana Munshi
Mar 4, 2009·Journal of General Internal Medicine·Mark H EckmanJonathan Rosand
Apr 26, 2012·Current Oncology Reports·Guru SonpavdeToni K Choueiri
Nov 8, 2011·Journal of Cardiovascular Translational Research·Mathieu PankertThomas Cuisset
May 4, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Yuval RamotGalia Spectre
Aug 16, 2012·The Journal of Laryngology and Otology·J R SavageP J Robinson
May 5, 2006·Nature Reviews. Drug Discovery·Vera Regitz-Zagrosek
Dec 3, 2008·Chemical Communications : Chem Comm·Benoit M LienardChristopher J Schofield
Mar 11, 2005·The New England Journal of Medicine·Marc S SabatineUNKNOWN CLARITY-TIMI 28 Investigators
Dec 2, 2005·The New England Journal of Medicine·Carlo PatronoColin Baigent
Dec 14, 2007·The New England Journal of Medicine·Giovanni Davì, Carlo Patrono
Apr 5, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nandan S AnavekarLarry M Baddour
Jun 7, 2007·Journal of the National Cancer Institute·Aditya BardiaJames R Cerhan
Aug 10, 2007·Journal of the National Cancer Institute·Frank A ScappaticciHerbert Hurwitz
Apr 22, 2006·Cardiology in Review·Theresa NguyenRobert G Lerner
Dec 20, 2005·Obstetrical & Gynecological Survey·Andra H JamesLeo R Brancazio
Oct 17, 2008·Cardiology in Review·Michael H KooWilliam H Frishman
Jul 29, 2009·American Journal of Therapeutics·Mukesh SinghRohit Arora
Aug 24, 2005·International Journal of Clinical Practice·R JaumdallyC Varma
Feb 19, 2009·International Journal of Clinical Practice·J B LiL Huang
Dec 25, 2009·Circulation. Cardiovascular Quality and Outcomes·Jeffrey S BergerSylvia Wassertheil-Smoller
Aug 30, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·Andrew P DeFilippisJeffrey J Rade
Feb 11, 2010·International Heart Journal·Kyeong Ho YunJin-Won Jeong
Jul 28, 2011·International Journal of Women's Health·Freek Wa Verheugt, Antoinette C Bolte
Aug 24, 2012·Patient Related Outcome Measures·Hussam M TayebMatthew I Worthley
Nov 9, 2010·Vascular Health and Risk Management·Runlin Gao, Xiaoying Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.